Resistin levels and inflammatory markers in patients with morbid obesity

被引:16
作者
De Luis, D. A.
Gonzalez Sagrado, M.
Conde, R.
Aller, R.
Izaola, O.
机构
[1] Univ Valladolid, Hosp Rio Hortega, Unit Invest, Valladolid 47130, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Sch Med, Inst Endocrinol & Nutr Clin, Valladolid 47130, Spain
关键词
Inflammatory markers; Morbid obesity; Resistin; INSULIN-RESISTANCE; SERUM RESISTIN; METABOLIC SYNDROME; ADIPONECTIN; ASSOCIATIONS; DISEASE; TISSUE;
D O I
10.3305/nh.2010.25.4.4478
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: The aim of the present study was to explore the relationship of resistin levels with inflammatory markers and anthropometric parameters in morbid obese patients. Subjects: A population of 46 morbid obese was analyzed. A complete nutritional and biochemical evaluation was performed. Patients were divided in two groups by median resistin value (3.49 ng/ml), group I(low values, average value 2.60 +/- 0.5) and group II (high values, average value 5.71 +/- 2.25). Results: Patients in the group II had higher weight, BMI, fat mass, waist circumference, LDL-cholesterol, triglycerides, fibrinogen and C reactive protein than patients in group I. In the multivariate analysis with age- and sex-adjusted basal resistin concentration as a dependent variable, only fibrinogen and LDL cholesterol remained as an independent predictor in the model (F = 8.5; p < 0.05). Resistin concentration increase 0.01 ng/ml (CI95%: 0.003-0.017) for each mg/dl of fibrinogen increased. Resistin concentration increase 0.03 ng/ml (CI95%: 0.003-0.049) for each mg/dl of LDL-cholesterol increased. Conclusion: Circulating resistin concentrations are associated with different inflammatory markers, triglycerides, LDL cholesterol and anthropometric variables in morbid obese patients. Further studies are needed to explore these interesting relationships.
引用
收藏
页码:630 / 634
页数:5
相关论文
共 29 条
[1]  
[Anonymous], DIABETOLOGIA
[2]   Correlation between serum resistin level and adiposity in obese individuals [J].
Azuma, K ;
Katsukawa, F ;
Oguchi, S ;
Murata, M ;
Yamazaki, H ;
Shimada, A ;
Saruta, T .
OBESITY RESEARCH, 2003, 11 (08) :997-1001
[3]   Relationships between human serum resistin, inflammatory markers and insulin resistance [J].
Bo, S ;
Gambino, R ;
Pagani, A ;
Guidi, S ;
Gentile, L ;
Cassader, M ;
Pagano, GF .
INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (11) :1315-1320
[4]   Cross-sectional associations of resistin, coronary heart disease, and insulin resistance [J].
Burnett, MS ;
Devaney, JM ;
Adenika, RJ ;
Lindsay, R ;
Howard, BV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :64-68
[5]   Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes [J].
Chu, NV ;
Caulfield, M ;
Kong, APS ;
Mudaliar, SR ;
Kim, DD ;
Reitz, R ;
Armstrong, D ;
Henry, RR ;
Baxi, S ;
Reaven, PD ;
Deutsch, R .
DIABETES CARE, 2002, 25 (03) :542-549
[6]   Lack of association of-55CT polymorphism of UCP3 gene with fat distribution in obese patients [J].
de Luis, D. A. ;
Aller, R. ;
Izaola, O. ;
Gonzalez Sagrado, M. ;
Conde, R. ;
Perez Castrillon, J. L. .
ANNALS OF NUTRITION AND METABOLISM, 2007, 51 (04) :374-378
[7]  
DELUIS DA, 2009, DIAB RES CL IN PRESS
[8]   Adipose tissue, adipokines, and inflammation [J].
Fantuzzi, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) :911-919
[9]  
Feurer I., 1986, NUTR CLIN PRACT, V1, P43, DOI DOI 10.1177/088453368600100106
[10]  
Iqbal N, 2005, Eur Rev Med Pharmacol Sci, V9, P161